awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853299-00DAE324-1D42-4E02-B0FE-5C7E79906DC9
Q27853299-00DAE324-1D42-4E02-B0FE-5C7E79906DC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853299-00DAE324-1D42-4E02-B0FE-5C7E79906DC9
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.
P2860
Q27853299-00DAE324-1D42-4E02-B0FE-5C7E79906DC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853299-00DAE324-1D42-4E02-B0FE-5C7E79906DC9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0c36214364996fedc389b210b22cf809bfdd3ee
P2860
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.